Date | Title | Description | Source |
29.03.2023 | 9 psychedelics startups that are winning over top venture in... | A handful of psychedelics companies have received interest from mainstream investors. jackfoto/iStoc... | businessin... |
17.02.2023 | These investor-backed mental health startups are healing our... | At least 1 in 5 people will experience mental illness at any time.
Yet for many, treatment is prohib... | tech.eu/20... |
24.01.2023 | The rise of venture debt: When biotechs should—and shouldn't... | Biotechs are operating on razor-thin margins, struggling in a market that just two years ago was flu... | fiercebiot... |
11.01.2023 | The CEO of a psychedelics giant that just suffered a big set... | Atai Life Sciences CEO Florian Brand. ATAI Life Sciences
This story is available exclusively to Insi... | businessin... |
04.10.2022 | ROTH Capital Partners to Host Inaugural Healthcare Opportuni... | Event to feature company presentations and one-on-one meetings between institutional investors and s... | einpresswi... |
06.09.2022 | atai Life Sciences to Participate in September Investor Even... | NEW YORK and BERLIN, Sept. 07, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. ATAI ("atai&quo... | einpresswi... |
15.08.2022 | Atai prunes pipeline, drops out of partnerships as it take... | Planning for the long haul, mental health-focused biotech atai Life Sciences has taken a hard l... | endpts.com... |
15.08.2022 | atai Life Sciences Secures Term Loan Facility for up to $175... | - Non-dilutive financing facility, plus $312M existing cash on hand as of June 30, 2022, gives atai ... | globenewsw... |
19.05.2022 | Can We Fix Ovarian Aging? Here Is One Startup Up For The Tas... | Concept of a healthy female reproductive system. getty | forbes.com... |
27.01.2022 | Atai Life Sciences Launches Invyxis to Accelerate Discovery ... | Invyxis will add proven medicinal chemistry and comprehensive biological evaluation capabilities to ... | marketscre... |
12.01.2022 | Atai Life Sciences announces FDA Investigational New Drug (I... | • Enables expansion of PCN-101 clinical development to the U.S.
• atai plans to initiate clinical dr... | marketscre... |
29.11.2021 | atai Life Sciences Increases Its Ownership Position in COMPA... | Demonstrates atai’s confidence in COMPASS’ Phase 2b data and its potential for patients with treatme... | aithority.... |
12.08.2021 | Manufacturing issues hold back distribution of over... | President Joe Biden on Thursday revealed key details of what he wants to see reformed in the pharmac... | endpts.com... |
12.08.2021 | Peter Thiel-backed ATAI launches new Salvia-focused biote... | ATAI Life Sciences, the Peter Thiel-backed umbrella developer of psychedelics and other dr... | endpts.com... |
12.08.2021 | A unicorn bags another $220M to fund its plans to upend ... | The focus on decentralized trials amid the pandemic has led investors to make some big bets ... | endpts.com... |
12.08.2021 | Manufacturing issues hold back distribution of overdose inje... | In April, Pfizer was forced to stop production of the injectable opioid antidote naloxone, after a m... | endpts.com... |
12.08.2021 | Merck partner Artiva blueprints San Diego R&D, manufactu... | In January, Artiva Biotherapeutics CEO Fred Aslan said his company is looking to create CAR-NK thera... | endpts.com... |
12.08.2021 | UPDATED: Out to revamp plant-based drug manufacturing, Anthe... | With supply chain shortages at the forefront of nearly every business in the world right now, whethe... | endpts.com... |
10.08.2021 | Indigenous Reciprocity Initiative of the Americas Website La... | The Indigenous Reciprocity Initiative gives back to Indigenous people through nurturing ecological w... | prweb.com/... |
15.07.2021 | Atai Life Sciences N : Leading U.S.-Based Psychedelic Health... | CHICAGO, July 15, 2021 /PRNewswire/ -- Palo Santo, the leading U.S.-based psychedelic investment fun... | marketscre... |
18.06.2021 | Psychedelics giant Atai is targeting a $2.3 billion valuatio... | Psilocybin found in magic mushrooms is a type of psychedelic Alexander Volkov/Getty Images This stor... | businessin... |
18.06.2021 | Thiel-backed psychedelics startup Atai valued at $3.19 bln i... | June 18 (Reuters) - Shares of Atai Life Sciences B.V. , backed by billionaire investor Peter Thiel, ... | marketscre... |
18.06.2021 | Thiel-backed psychedelics startup Atai valued at over $3 bln... | June 18 (Reuters) - Shares of Atai Life Sciences B.V., backed by billionaire investor Peter Thiel, j... | marketscre... |
18.06.2021 | Thiel-backed psychedelics startup Atai valued at $3.19 billi... | (Reuters) -Shares of Atai Life Sciences B.V., backed by billionaire investor Peter Thiel, surged 40%... | saltwire.c... |
11.06.2021 | German psychedelic startup Atai targets valuation of $2.3 bi... | (Reuters) - Atai Life Sciences B.V., backed by billionaire investor Peter Thiel, said on Friday it w... | saltwire.c... |
03.06.2021 | Psychedelic healthcare fund Neo Kuma sees early success amid... | The UK’s first investment fund dedicated solely to psychedelic healthcare, Neo Kuma is reporting tha... | tech.eu/br... |
22.04.2021 | Peter Thiel's psychedelic drug startup Atai eyes $100M IPO | Peter Thiel (Neilson Barnard/Getty Images)
Investor interest in psychedelic-based medicine has incre... | pitchbook.... |
09.04.2021 | Peter Thiel-backed psychedelic startup ATAI Life Sciences ta... | We covered ATAI Life Sciences (ATAI) back in the winter of 2020 after the Peter Thiel-backed startup... | techstartu... |
04.03.2021 | atai Life Sciences Closes $157M Series D Financing Round | atai Life Sciences, a Berlin, Germany-based clinical-stage biopharmaceutical company developing psyc... | finsmes.co... |
03.03.2021 | Thiel-backed psychedelic startup Atai raises another $157m | Berlin-headquartered biotech firm Atai Life Sciences, which specialises in psychedelic treatments fo... | sifted.eu/... |
15.01.2021 | Mental health companies that raised funding in 2020 | Headspace, Lyra, Koa Health, Ginger, and Spring Health were among those that saw new investments
202... | vator.tv/n... |
27.11.2020 | Peter Thiel backs German startup that develops psychedelic t... | The coronavirus pandemic has sent a shockwave across the world, taking an unprecedented toll on our ... | siliconcan... |
24.11.2020 | Peter Thiel backs Berlin startup ATAI Life Sciences in $125M... | Almost a billion people suffer from mental health problems worldwide, according to the World Health ... | techstartu... |
24.11.2020 | Another Bet on Psychedelic Drugs: Atai Raises $125 Million | With investors taking psychedelic drugs seriously as potential treatments for intractable cases of d... | barrons.co... |
23.11.2020 | ATAI snags $125M to bankroll mental health pipeline | ATAI Life Sciences is topping off a busy year with a $125 million financing, which will support the ... | fiercebiot... |
23.11.2020 | ATAI Life Sciences Closes $125 Million Series C Financing | ATAI Life Sciences, a global biotech company developing psychedelic and non-psychedelic compounds fo... | citybizlis... |
23.11.2020 | ATAI snags $125M to bankroll mental health pipeline
W h i t... | ATAI Life Sciences is topping off a busy year with a $125 million financing, which will support the ... | fiercebiot... |
24.08.2020 | ATAI Life Sciences launches EmpathBio to treat post-traumati... | | prnewswire... |
28.02.2020 | ATAI has raised $100 million to turn psychedelics into treat... | Shutterstock
Psilocybin, the main psychoactive ingredient in hallucinogenic mushrooms, could help tr... | businessin... |
02.04.2019 | Germany-Based ATAI Life Sciences Raises $43 Million To Cure ... | ATAI Life Sciences, a Munich, Germany-based global biotech platform company that is focused on curin... | pulse2.com... |
29.03.2019 | Term Sheet — Friday, March 29 | THE SMALL IPO IS DEAD
I’ll never forget Lyft president John Zimmer’s comment at Fortune’s Brainstorm... | fortune.co... |
28.03.2019 | Atai Life Sciences Closes $43M Series B Financing | Atai Life Sciences, a Berlin, Germany- London, UK- and New York-based biotech platform dedicated to ... | finsmes.co... |
28.03.2019 | Daily funding roundup - March 28th, 2019 | BillionToOne raised $15M; Polyneuron Pharmaceuticals secured $22.6M;Prevail Therapeutics lands $50M
... | vator.tv/n... |
27.03.2019 | ATAI Life Sciences Closes $43 Million Series B Financing Rou... | NEW YORK & LONDON & BERLIN--(BUSINESS WIRE)--ATAI Life Sciences, the global biotech platform... | archive.ci... |
27.03.2019 | ATAI Life Sciences Closes $43 Million Series B Financing Rou... | NEW YORK & LONDON & BERLIN--(BUSINESS WIRE)--ATAI Life Sciences, the global biotech platform... | citybizlis... |
03.01.2019 | ATAI Life Sciences acquires majority stake in Perception Neu... | Munich and New York, 03 January 2019 - ATAI Life Sciences AG has acquired a majority stake in New Yo... | realwire.c... |
- | The legal psychedelics industry: capitalism on drugs | On April 19, the Fontainebleau Miami Beach hotel hosted the inaugural Benzinga Psychedelics Capital ... | aljazeera.... |
- | 2022 has been a 'lost year in terms of valuation' for Christ... | Christian Angermayer, founder of Apeiron Investment Group Apeiron Investment Group This story is ava... | businessin... |
- | Psychedelic healthcare fund Neo Kuma sees early success amid... | The UK’s first investment fund dedicated solely to psychedelic healthcare, Neo Kuma is reporting tha... | tech.eu/20... |
- | Startups are measuring your brain waves and analyzing your v... | Getty Images This story is available exclusively to Insider subscribers. Become an Insider and start... | businessin... |
- | The biggest private psychedelics company in the world just r... | Psilocybin found in magic mushrooms is a type of psychedelic Alexander Volkov/Getty Images This stor... | businessin... |
- | Civilized founders pushed out | As the legal cannabis market grows in the US, there are many ways for investors to gain exposure to ... | businessin... |